The Story cover image

The children taking Wegovy

The Story

00:00

Regulatory Evidence and the StepTeens Trial

Roisin summarises the StepTeens trial results, its size, outcomes and how regulators used it to license Wegovy for 12–17 year olds.

Play episode from 05:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app